Cargando…

Sources

Detalles Bibliográficos
Autor principal:	Zanchin, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2004
Materias:	History of Headache Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749063/ http://dx.doi.org/10.1007/s10194-004-0140-3

Ejemplares similares

New additions to the History of Headache Section
por: Zanchin, Giorgio
Publicado: (2004)

Headache among the educated in the century of enlightment
por: Zanchin, Giorgio, et al.
Publicado: (2004)

The nervous system in colours: the tabulae pictae of G.F. d’Acquapendente (ca. 1533–1619)
por: Zanchin, G., et al.
Publicado: (2006)

Introduction to the History of Headache Section
Publicado: (2004)

Concepts leading to the definition of the term cervicogenic headache: a historical overview
por: Antonaci, F., et al.
Publicado: (2005)

Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases
por: Sjaastad, Ottar
Publicado: (2006)

The History of the Migraine Trust
por: Rose, F. C.
Publicado: (2006)

Section editor note
por: Zanchin, Giorgio
Publicado: (2006)

When cluster headache was called histaminic cephalalgia (Horton’s headache)
por: Fanciullacci, M.
Publicado: (2006)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up
por: Maggioni, F., et al.
Publicado: (2005)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

Habituation of single CO(2) laser–evoked responses during interictal phase of migraine
por: de Tommaso, M., et al.
Publicado: (2005)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Review of Prevention for Pediatric and Adolescent Migraine
por: Qubty, William, et al.
Publicado: (2016)

Acute Treatment Regimens for Migraine in the ED
por: Millichap, J. Gordon
Publicado: (2015)

Intracranial Hypertension in Children without Papilledema
por: Chelse, Ana B., et al.
Publicado: (2015)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Cyclic AMP Accumulation in Migraine Induction
por: Chelse, Ana B., et al.
Publicado: (2015)

Pediatric Intracranial Hypertension
por: Sivaswamy, Lalitha
Publicado: (2016)

Basic Considerations for the Use of Monoclonal Antibodies in Migraine
por: Levin, Morris, et al.
Publicado: (2018)

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials
por: Hindiyeh, Nada A., et al.
Publicado: (2019)

Multivariate classification of pain-evoked brain activity in temporomandibular disorder
por: Harper, Daniel E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_esjbqnckebldksrbrbitvmi2t3